Tensi+ for Treating Overactive Bladder
NCT: NCT07300904 · NOT_YET_RECRUITING
NCT IDNCT07300904
StatusNOT_YET_RECRUITING
Start Date2026-05
Completion2027-01
Brief Summary
The purpose of the study is to evaluate the safety and effectiveness of the Tensi+ device using Transcutaneous Posterior Tibial Nerve Stimulation (TPTNS) for treating patients suffering from OAB symptoms urinary frequency, urgency, with or without urge urinary incontinence.
Frequently Asked Questions
What is Tensi+ for Treating Overactive Bladder?
Tensi+ for Treating Overactive Bladder is a clinical trial registered under NCT07300904. Current status: NOT_YET_RECRUITING.
What is the status of NCT07300904?
The current status of NCT07300904 (Tensi+ for Treating Overactive Bladder) is: NOT_YET_RECRUITING.
When did Tensi+ for Treating Overactive Bladder start?
Tensi+ for Treating Overactive Bladder started on 2026-05.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.